|
XPR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53510000000723E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.438500E-03 |
| Normal-vs-Stage2 |
5.055700E-02 |
| Normal-vs-Stage3 |
7.598200E-04 |
| Normal-vs-Stage4 |
1.94819999999041E-06 |
| Stage1-vs-Stage2 |
6.262000E-01 |
| Stage1-vs-Stage3 |
1.173210E-01 |
| Stage1-vs-Stage4 |
7.437500E-03 |
| Stage2-vs-Stage3 |
5.081400E-01 |
| Stage2-vs-Stage4 |
1.281390E-01 |
| Stage3-vs-Stage4 |
3.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.598400E-04 |
| Normal-vs-AfricanAmerican |
4.74820183171687E-11 |
| Normal-vs-Asian |
6.686800E-01 |
| Caucasian-vs-AfricanAmerican |
1.87038999999167E-05 |
| Caucasian-vs-Asian |
2.110200E-01 |
| AfricanAmerican-vs-Asian |
8.597900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42630000002464E-06 |
| Normal-vs-Female |
2.275900E-02 |
| Male-vs-Female |
5.185900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.377000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.048400E-04 |
| Normal-vs-Age(61-80Yrs) |
5.020700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.686020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.122000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.290000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.498000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.793000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.995800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.911000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.869200E-01 |
| Normal-vs-Grade 2 |
3.045800E-02 |
| Normal-vs-Grade 3 |
1.245670E-04 |
| Normal-vs-Grade 4 |
6.96059999638621E-08 |
| Grade 1-vs-Grade 2 |
9.680000E-01 |
| Grade 1-vs-Grade 3 |
5.341400E-01 |
| Grade 1-vs-Grade 4 |
6.599900E-02 |
| Grade 2-vs-Grade 3 |
1.325380E-01 |
| Grade 2-vs-Grade 4 |
3.020800E-04 |
| Grade 3-vs-Grade 4 |
1.129620E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.921800E-01 |
| Normal-vs-ccB subtype |
4.0256999999988E-05 |
| ccA subtype-vs-ccB subtype |
3.96030000000547E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.138600E-03 |
| Normal-vs-N1 |
5.838000E-01 |
| N0-vs-N1 |
7.965600E-01 |
|
|
